EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV

Federica Frasca iD, Luca Maddaloni, Alessandra D'Auria, Matteo Fracella, Ginevra Bugani, Carmen Falvino, Valentina Baccolini, Giuseppe Migliara, Francesca Aloisi, Letizia Santinelli, Enrico Palermo, Luca Bortolani iD und 7 weitere

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Federica Frasca und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Life Sciences, European University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, HIV Infections, Interferon Type I, Antibodies, Viral. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carolina Scagnolari from Gilead Sciences, Sapienza University of Rome, Sapienza Università di Roma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examined changes in anti‐Spike (anti‐S) antibodies (Abs) and type I interferon (IFN‐I) following the BNT162b2 vaccine in people living with HIV (PLWH) and analyzed the impact of demographic and immunological factors. In total, 75 PLWH and 28 healthy donors were followed at baseline (T0), at the second dose (T1), after the second dose (T2), and more than 1 year later (T3). Anti‐S Abs were assessed by chemiluminescence and vesicular stomatitis virus (VSV)‐based pseudo virus‐neutralization assay, while IFN‐α2, IFN‐β, and IFN‐ω mRNA levels were measured by RT‐Real Time PCR. PLWH showed an increase in anti‐S Immunoglobulin G (IgG) levels comparable to healthy donors ( p < 0.001) and an induction of anti‐S neutralizing Abs ( p < 0.014 for T2 vs. T3). Age, gender, CD4 + T cell count, exposure to combined antiretroviral therapy (cART) and IFN‐I levels at T0 did not affect the anti‐S IgG production. IFN‐I gene expression showed temporal changes, with a decrease at T2 ( p < 0.01) and a subsequent increase at T3 ( p < 0.001, for IFN‐α2 and IFN‐ω). A multivariable model revealed no overall change in the IFN‐I response over time, except for IFN‐β, which was lower at T3 than at T1 ( p = 0.032). CD4 + T cell count was positively correlated with the IFN‐I response ( p < 0.05). These results suggest that mRNA vaccination can elicit an effective anti‐S response and modulate the IFN‐β gene expression in PLWH, with CD4 + T cell count being a key determinant of vaccine‐induced changes in IFN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingHIV InfectionsInterferon Type IAntibodies, ViralBNT162 VaccineSARS-CoV-2COVID-19COVID-19 VaccinesHumansFemaleMaleAdultMiddle AgedImmunoglobulin GVaccination

Stichwörter der Autor:innen

BNT162b2 COVID‐19 vaccineHIVanti‐Spike antibodiesinterferon

Substanzen

Antibodies, NeutralizingInterferon Type IAntibodies, ViralBNT162 VaccineImmunoglobulin GCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Health and Life Sciences, European University of Rome, Rome, Italy.
  • Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
  • Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy.
  • Department of Life Sciences, Health and Health Professions, Link Campus University, Rome, Italy.
  • Istituto Pasteur Italia-Cenci Bolognetti Foundation, Rome, Italy.

ORCID-Profile: Federica Frasca, Luca Bortolani, Alessandro Lazzaro, Gabriella d'Ettorre, Carolina Scagnolari

Förderung

  • Carolina Scagnolari from Gilead Sciences
  • Sapienza University of Rome
  • Sapienza Università di Roma

Zitieren

APA

Frasca, F., Maddaloni, L., D'Auria, A., Fracella, M., Bugani, G., Falvino, C., Baccolini, V., Migliara, G., Aloisi, F., Santinelli, L., Palermo, E., Bortolani, L., Lazzaro, A., Ceccarelli, G., Turriziani, O., Mastroianni, C. M., Antonelli, G., d'Ettorre, G., & Scagnolari, C. (2026). SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV. Journal of Medical Virology. https://doi.org/10.1002/jmv.71067

Vancouver

Frasca F, Maddaloni L, D'Auria A, Fracella M, Bugani G, Falvino C, et al. SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV. Journal of Medical Virology. 2026. doi:10.1002/jmv.71067

BibTeX
@article{Frasca2026,
  author = {Frasca, Federica and Maddaloni, Luca and D'Auria, Alessandra and Fracella, Matteo and Bugani, Ginevra and Falvino, Carmen and Baccolini, Valentina and Migliara, Giuseppe and Aloisi, Francesca and Santinelli, Letizia and Palermo, Enrico and Bortolani, Luca and Lazzaro, Alessandro and Ceccarelli, Giancarlo and Turriziani, Ombretta and Mastroianni, Claudio Maria and Antonelli, Guido and d'Ettorre, Gabriella and Scagnolari, Carolina},
  title = {SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71067}
}
Kostenlos starten →